{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["C-fos", "Caesalpinia gilliesii", "GSK-3\u03b2", "Galactomannan", "HepG2", "Hepatocellular carcinoma", "NF-\u03baB", "TNF-\u03b1"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30030776", "DateCompleted": {"Year": "2019", "Month": "03", "Day": "08"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "07", "Day": "20"}], "Language": ["eng"], "ELocationID": ["10.1007/s11010-018-3404-y"], "Journal": {"ISSN": "1573-4919", "JournalIssue": {"Volume": "451", "Issue": "1-2", "PubDate": {"Year": "2019", "Month": "Jan"}}, "Title": "Molecular and cellular biochemistry", "ISOAbbreviation": "Mol Cell Biochem"}, "ArticleTitle": "Regulation of apoptotic and inflammatory signaling pathways in hepatocellular carcinoma via Caesalpinia gilliesii galactomannan.", "Pagination": {"StartPage": "173", "EndPage": "184", "MedlinePgn": "173-184"}, "Abstract": {"AbstractText": ["A polysaccharide characterized as galactomannan (GMann) with a molecular weight of 117.76\u00a0kDa was isolated from the aqueous extract of Caesalpinia gilliesii (C. gilliesii) seeds then assessed for antiproliferative potential against human hepatocellular carcinoma cell line (HepG2). Further, HCC was induced in Wister albino rats by Diethylnitrosamine (DEN) ip injection (200\u00a0mg/kg\u00a0bw), and CCl4 orally (2\u00a0ml/kg\u00a0bw) for two months then subjected to GMann orally treatment (2\u00a0mg/kg\u00a0bw) for one month. In results, isolated GMann is constituted of sugars (89.99\u2009\u00b1\u20092.3%), moisture (6.89\u2009\u00b1\u20090.45%), ash (0.06\u2009\u00b1\u20090.2%), and protein (2.81%) and composed mainly of mannose and galactose in ratio M/G 3.79. In vitro study, data revealed a concentration-dependent potency of GMann to induce cell death of HepG2 cells with IC<sub>50</sub> value of 0.375\u00a0\u00b5g/ml. Mechanistic studies revealed the potential of GMann to arrest cell cycle at G2/M phase with induction of apoptosis. Biochemical results in vivo showed a significant reduction in serum transaminases (ALT and AST) as well as hepatic malondialdehyde (MDA) and nitric oxide (NOx). Molecular analysis declared a significant down-regulation in mRNA gene expression of both nuclear factor kappa-B (NF-\u03baB) and tumor necrosis factor (TNF-\u03b1). Furthermore, a significant down-regulation in the cellular oncogene-fos (C-fos) and marked up-regulation in Glycogen synthase kinase-3 (GSK-3\u03b2) level were observed. These results were supported with histopathological investigation. Whereas GMann improved inflammatory and apoptotic markers, it could be a promising new therapeutic agent for HCC suppression and this warrant further development as a possible drug candidate for HCC."]}, "AuthorList": [{"Identifier": ["0000-0001-8113-8834"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Therapeutic Chemistry Department, National Research Centre, El Buhouth St., Dokki, Giza, 12622, Egypt. rehabzenbaa@gmail.com."}], "LastName": "Abdel-Megeed", "ForeName": "Rehab M", "Initials": "RM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry of Medicinal Plants Department & Pharmaceutical Research Division Biology Unit, Central Laboratory Network, Lab 610, Floor 6, National Research Centre, El Buhouth St., Dokki, Giza, 12622, Egypt."}], "LastName": "Hamed", "ForeName": "Ahmed R", "Initials": "AR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, National Research Centre, El Buhouth St., Dokki, Giza, 12622, Egypt."}], "LastName": "Matloub", "ForeName": "Azza A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Therapeutic Chemistry Department, National Research Centre, El Buhouth St., Dokki, Giza, 12622, Egypt."}], "LastName": "Kadry", "ForeName": "Mai O", "Initials": "MO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Therapeutic Chemistry Department, National Research Centre, El Buhouth St., Dokki, Giza, 12622, Egypt."}], "LastName": "Abdel-Hamid", "ForeName": "Abdel-Hamid Z", "Initials": "AZ"}], "GrantList": [{"GrantID": "5510", "Agency": "Science and Technology Development Fund", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Mol Cell Biochem", "NlmUniqueID": "0364456", "ISSNLinking": "0300-8177"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Mannans"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "11078-30-1", "NameOfSubstance": "galactomannan"}, {"RegistryNumber": "X2RN3Q8DNE", "NameOfSubstance": "Galactose"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["chemistry"], "DescriptorName": "Caesalpinia"}, {"QualifierName": ["drug therapy", "immunology", "metabolism", "pathology"], "DescriptorName": "Carcinoma, Hepatocellular"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["analogs & derivatives"], "DescriptorName": "Galactose"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "immunology", "metabolism", "pathology"], "DescriptorName": "Inflammation"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Liver"}, {"QualifierName": ["drug therapy", "immunology", "metabolism", "pathology"], "DescriptorName": "Liver Neoplasms"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Mannans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": [], "DescriptorName": "Tumor Cells, Cultured"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Nitric Oxide. 2001 Feb;5(1):62-71", "ArticleIdList": ["11178938"]}, {"Citation": "Prog Neurobiol. 2001 Nov;65(4):391-426", "ArticleIdList": ["11527574"]}, {"Citation": "Methods. 2001 Dec;25(4):402-8", "ArticleIdList": ["11846609"]}, {"Citation": "Nat Rev Immunol. 2003 Sep;3(9):745-56", "ArticleIdList": ["12949498"]}, {"Citation": "Am J Clin Pathol. 1957 Jul;28(1):56-63", "ArticleIdList": ["13458125"]}, {"Citation": "J Biol Chem. 2003 Dec 5;278(49):48872-9", "ArticleIdList": ["14523002"]}, {"Citation": "Nat Rev Cancer. 2003 Nov;3(11):859-68", "ArticleIdList": ["14668816"]}, {"Citation": "Altern Lab Anim. 2003 Mar-Apr;31(2):89-198", "ArticleIdList": ["15612878"]}, {"Citation": "J Cell Biol. 2005 Feb 14;168(4):561-6", "ArticleIdList": ["15699216"]}, {"Citation": "J Colloid Interface Sci. 2007 May 15;309(2):373-83", "ArticleIdList": ["17316669"]}, {"Citation": "Mutat Res. 2009 Mar 31;674(1-2):36-44", "ArticleIdList": ["18977455"]}, {"Citation": "J Med Virol. 2010 Apr;82(4):539-45", "ArticleIdList": ["20166172"]}, {"Citation": "Int Immunopharmacol. 2011 Jun;11(6):652-60", "ArticleIdList": ["21255695"]}, {"Citation": "J Exp Clin Cancer Res. 2011 Sep 26;30:87", "ArticleIdList": ["21943236"]}, {"Citation": "Genes Cancer. 2012 Jan;3(1):23-36", "ArticleIdList": ["22893788"]}, {"Citation": "Carbohydr Polym. 2013 Jan 30;92(1):479-83", "ArticleIdList": ["23218323"]}, {"Citation": "Int J Med Sci. 2013;10(6):683-90", "ArticleIdList": ["23569432"]}, {"Citation": "Int J Biol Macromol. 2013 Sep;60:93-9", "ArticleIdList": ["23707733"]}, {"Citation": "Environ Toxicol Pharmacol. 2013 Sep;36(2):303-10", "ArticleIdList": ["23708311"]}, {"Citation": "Carbohydr Polym. 2013 Nov 6;98(2):1466-75", "ArticleIdList": ["24053828"]}, {"Citation": "Int J Biol Macromol. 2014 Apr;65:167-75", "ArticleIdList": ["24456898"]}, {"Citation": "J Med Chem. 2014 Aug 28;57(16):6930-48", "ArticleIdList": ["24831826"]}, {"Citation": "Methods Enzymol. 2014;545:1-33", "ArticleIdList": ["25065884"]}, {"Citation": "Hepatology. 2014 Dec;60(6):2099-108", "ArticleIdList": ["25164003"]}, {"Citation": "J Agric Food Chem. 2015 Apr 1;63(12):3219-28", "ArticleIdList": ["25756601"]}, {"Citation": "Nat Rev Immunol. 2015 Jun;15(6):362-74", "ArticleIdList": ["26008591"]}, {"Citation": "Liver Cancer. 2015 Mar;4(1):39-50", "ArticleIdList": ["26020028"]}, {"Citation": "Pharm Biol. 2016 Jul;54(7):1223-36", "ArticleIdList": ["26154521"]}, {"Citation": "Sci Rep. 2015 Aug 21;5:13249", "ArticleIdList": ["26292722"]}, {"Citation": "Oxid Med Cell Longev. 2016;2016:2428153", "ArticleIdList": ["26682001"]}, {"Citation": "Biomed Res Int. 2016;2016:7658981", "ArticleIdList": ["27051670"]}, {"Citation": "Clin Cancer Res. 2017 Jun 15;23(12):3120-3128", "ArticleIdList": ["27965308"]}, {"Citation": "J Clin Oncol. 2017 Mar;35(7):734-742", "ArticleIdList": ["28068175"]}, {"Citation": "Mol Med Rep. 2017 May;15(5):2991-3000", "ArticleIdList": ["28358415"]}, {"Citation": "Nat Commun. 2017 Oct 10;8(1):839", "ArticleIdList": ["29018224"]}, {"Citation": "PeerJ. 2017 Oct 6;5:e3862", "ArticleIdList": ["29018607"]}, {"Citation": "Anal Biochem. 1979 Jun;95(2):351-8", "ArticleIdList": ["36810"]}, {"Citation": "J Immunol Methods. 1983 Dec 16;65(1-2):55-63", "ArticleIdList": ["6606682"]}, {"Citation": "Br J Cancer. 1978 Aug;38(2):302-9", "ArticleIdList": ["698046"]}, {"Citation": "Biochim Biophys Acta. 1979 Jan 4;582(1):67-78", "ArticleIdList": ["760819"]}, {"Citation": "J Biol Chem. 1979 Jan 25;254(2):453-8", "ArticleIdList": ["762073"]}, {"Citation": "Annu Rev Cell Biol. 1993;9:317-43", "ArticleIdList": ["8280464"]}]}], "History": [{"Year": "2018", "Month": "2", "Day": "14"}, {"Year": "2018", "Month": "7", "Day": "13"}, {"Year": "2018", "Month": "7", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "3", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "22", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30030776", "10.1007/s11010-018-3404-y", "10.1007/s11010-018-3404-y"]}}]}